Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nienke Solleveld-Westerink

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancers|August 25, 2019
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell CancerMehtap Derya Aydemirli, Willem Corver, Ruben Beuk, et al.
Histopathology|April 3, 2020
Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinomaKim E Kortekaas, Nienke Solleveld-Westerink, Basile Tessier-Cloutier, et al.
Cancer Research|December 14, 2021
Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer RiskRick A C M Boonen, Wouter W Wiegant, Nandi Celosse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Cancers|October 2, 2020
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian CarcinomasLise M van Wijk, Sylvia Vermeulen, Matty Meijers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA SequencingDanielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
Cell Genomics|October 15, 2024
Complex structural variation is prevalent and highly pathogenic in pediatric solid tumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
Frontiers in Immunology|January 31, 2020
Apparent Lack of <i>BRAF</i><sup></sup> Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8<sup>+</sup> T Cells in Langerhans Cell HistiocytosisPaul G Kemps, Timo C Zondag, Eline C Steenwijk, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancers|August 25, 2019
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell CancerMehtap Derya Aydemirli, Willem Corver, Ruben Beuk, et al.
Histopathology|April 3, 2020
Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinomaKim E Kortekaas, Nienke Solleveld-Westerink, Basile Tessier-Cloutier, et al.
Cancer Research|December 14, 2021
Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer RiskRick A C M Boonen, Wouter W Wiegant, Nandi Celosse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Cancers|October 2, 2020
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian CarcinomasLise M van Wijk, Sylvia Vermeulen, Matty Meijers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA SequencingDanielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
Cell Genomics|October 15, 2024
Complex structural variation is prevalent and highly pathogenic in pediatric solid tumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
Frontiers in Immunology|January 31, 2020
Apparent Lack of <i>BRAF</i><sup></sup> Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8<sup>+</sup> T Cells in Langerhans Cell HistiocytosisPaul G Kemps, Timo C Zondag, Eline C Steenwijk, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Pageof 1